1-3 of 3
Jesse Smith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 807: Mechanism of action of synergistic activity of EZH2 inhibition and IMiDs in preclinical multiple myeloma models

Allison E. Drew, Vinny Motwani, Lindsey Eichinger, Jesse Smith, Alejandra Raimondi
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 807.
DOI: https://doi.org/10.1158/1538-7445.AM2018-807
Published: 01 July 2018
View article
Journal Articles

Abstract 5376: Identification of the first small molecule PRMT6 inhibitor tool compound

Allison Drew, Lorna Mitchell, Nathalie Rioux, Kerren Swinger, Scott Ribich, Suzanne Jacques-O'hagan, Trupti Lingaraj, Tim Wigle, Tom Riera, Richard Chesworth, Jesse Smith
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 5376.
DOI: https://doi.org/10.1158/1538-7445.AM2015-5376
Published: 01 August 2015
View article
Journal Articles

Abstract LB-248: Protein arginine methyltransferase 5 (PRMT5) inhibition as a therapeutic strategy in B-cell lymphoma

Olena Barbash, Sarah Gerhart, David Soong, Christine Thompson, Rocio Montes de Oca, Ping Zhang, Charles McHugh, Kristy Kuplast, Christina Majer, Richard Chesworth, Jesse Smith, Robert Copeland, Elayne Penebre, Kenneth Duncan, Neil Johnson, Chris Carpenter, Ryan Kruger
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): LB-248.
DOI: https://doi.org/10.1158/1538-7445.AM2015-LB-248
Published: 01 August 2015
View article